|
Usana Health Sciences Inc (NYSE: USNA) |
|
Usana Health Sciences Inc
USNA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Usana Health Sciences Inc 's sales fell
by -3.47 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1820
Legal Cannabis industry recorded
growth of revenues by 5.92 %
Usana Health Sciences Inc 's net profit decreased by -73.26 % in IV. Quarter 2024 year on year, to $4 millions.
• More on USNA's Growth
|
|
Usana Health Sciences Inc current PE on trailing twelve month basis is above Legal Cannabis industry average.
Usana Health Sciences Inc realized cash reduction of $ -7.75 per share in trailing twelve-month period. Legal Cannabis industry recorded net loss in trailing twelve months. |
Company |
12.72 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.63.
Legal Cannabis industry's Price to Sales ratio is at 9.58.
• More on USNA's Valuation
|
|
|
|
|
Usana Health Sciences Inc current PE on trailing twelve month basis is above Legal Cannabis industry average.
Usana Health Sciences Inc realized cash outflow of $ -7.75per share in trailing twelve-month period. Legal Cannabis industry recorded net loss in trailing twelve months. |
Company |
12.72 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.63.
Legal Cannabis industry's Price to Sales ratio is at 9.58.
Usana Health Sciences Inc Price to Book Ratio is at 1.01 lower than Industry Avg. of 666.72. and higher than S&P 500 Avg. of 0.01
• More on USNA's Valuation
|
|
USNA's Profitability Comparisons
|
Usana Health Sciences Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 3.84 % from 7.8 % in III. Quarter.
Usana Health Sciences Inc net profit margin of 2.09 % is currently ranking no. 7 in Legal Cannabis industry, ranking no. 81 in Consumer Non Cyclical sector and number 2167 in S&P 500.
Profitability by Segment |
Total |
5.3 % |
|
|
Usana Health Sciences Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 3.84 % from 7.8 % in III. Quarter.
Usana Health Sciences Inc net profit margin of 2.09 % is currently ranking no. 7 in Legal Cannabis industry, ranking no. 81 in Consumer Non Cyclical sector and number 2167 in S&P 500.
• More on USNA's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com